Type 2 diabetes medicine may reduce the risk of death

Jardiance, a pill to treat type 2 diabetes, can significantly reduce the risk of death among diabetics who are more likely to experience cardiovascular complications.

Diabetes medications can reduce the risk of death

The results of a study showed that this type of pill used daily for patients with type 2 diabetes can help patients reduce the risk of death from cardiovascular complications by 38%, reducing the risk of death due to the Other complications, and a 35% reduction in the risk of hospitalization for heart failure.

The results are especially impressive because about 80% of the study participants use standard medicines to control blood sugar, blood pressure and stroke prevention.

Illustration.(Source: nutraingredients.com).

This large-scale study involved 7,020 patients in 42 countries and with an average follow-up of 3 years. Two pharmaceutical companies producing Jardiance drugs are Eli Lilly & Co. and Boehringer Ingelheim Pharmaceuticals Inc. sponsored the project.

Speaking for reporters, Dr. Silvio Inzucchi of the Yale University Diabetes Center in the US said that for the first time, a diabetes medicine has been shown to reduce the risk of death from cardiovascular disease.

Jardiance can reduce 14% of diabetics with heart attack, stroke and death from cardiovascular complications. This result is quite attractive for patients and insurance companies, although the cost is quite high, the price of the drug taken daily to about 350 USD / month.

Cardiovascular complications are the leading cause of death among diabetics. Myocardial infarction, stroke, and other types of coronary arteries cause half of all type 2 diabetes patients to die, because the sugar level is too high in the blood to damage the heart and blood vessels, and the another agency.

If people have ever had a heart attack or stroke, having diabetes can reduce their life expectancy by 12 years.Jardiance drugs are used to increase blood sugar levels excreted in the urine.